Free Trial

These Are the Only 6 Stock Stocks in NVIDIA's 13F Portfolio

KYIV, UKRAINE - JANUARY 29, 2025 Nvidia corporation logotype showed on iPhone 15 smartphone display screen. Nvidia is a global leader in artificial intelligence hardware and software — Stock Editorial Photography

Key Points

  • NVIDIA's 13F filing provides investors a look at where this tech giant is investing over $1 billion.
  • The companies have a commonality between them that helps give NVIDIA specialized insight into their businesses.
  • How the returns of many of these stocks have played out after the initial NVIDIA pop may be surprising.
  • Five stocks we like better than NVIDIA.

NVIDIA Today

NVIDIA Co. stock logo
NVDANVDA 90-day performance
NVIDIA
$133.93 +2.13 (+1.62%)
As of 03:29 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
52-Week Range
$86.62
$195.95
Dividend Yield
0.03%
P/E Ratio
52.64
Price Target
$164.84

Many investors closely watch 13F filings from institutional money managers. While chip giant NVIDIA NASDAQ: NVDA isn’t typically seen in that role, it must file as well, since it manages over $100 million in U.S.-traded securities.

Below is a breakdown of the six stocks listed on NVIDIA’s most recent 13F.

Examining these holdings provides insight into the types of technology that this pioneering company is betting on.

All return data calculates the change in price through the May 21 close, since NVIDIA revealed its initial stake in these companies, including their initial rise.

NVIDIA’s Top 3 Chip and AI Infrastructure Investments Don’t Fall Far From the Tree

ARM Today

Arm Holdings plc stock logo
ARMARM 90-day performance
ARM
$129.81 -0.64 (-0.49%)
As of 03:29 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
52-Week Range
$80.00
$188.75
P/E Ratio
170.65
Price Target
$152.76

By far, NVIDIA’s largest 13F holding was CoreWeave NASDAQ: CRWV.

CoreWeave accounted for 78% of NVIDIA’s total reported 13F holdings in Q1.

Aside from owning approximately 7% of CoreWeave, the company is also one of NVIDIA’s biggest customers. 

CoreWeave uses its close relationship with NVIDIA to rent out the company’s most advanced AI chips to customers before anyone else.

On its last earnings call, CoreWeave said it was the first to deploy NVIDIA’s GB200 Grace Blackwell systems at scale.

Since going public in March, CoreWeave has increased by a staggering 169%, driven largely by the excitement surrounding its NVIDIA relationship.

ARM Today

Arm Holdings plc stock logo
ARMARM 90-day performance
ARM
$129.81 -0.64 (-0.49%)
As of 03:29 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
52-Week Range
$80.00
$188.75
P/E Ratio
170.65
Price Target
$152.76

The next two largest NVIDIA 13F holdings are Arm NASDAQ: ARM and Applied Digital NASDAQ: APLD.

They represent around 10% and 4% of NVIDIA’s total $1.15 billion 13F portfolio

NVIDIA actually tried to fully acquire ARM in 2020 for $40 billion; however, the transaction fell through due to regulatory issues.

ARM provides “IP cores," essentially the basic designs of chips that companies base their advanced chips on.

As such, ARM is a very important but somewhat underappreciated player in semiconductors.

Applied Digital Today

Applied Digital Co. stock logo
APLDAPLD 90-day performance
Applied Digital
$7.59 +0.81 (+11.95%)
As of 03:10 PM Eastern
52-Week Range
$3.01
$12.48
Price Target
$10.91

Applied Digital is somewhat similar to CoreWeave, renting out computing power to customers.

However, it still gets a good amount of its revenue from cryptocurrency miners, something that CoreWeave no longer dabbles in.

The company is also tiny, comparatively, worth only around $1.5 billion.

Since November 2024, when NVIDIA first reported owning Applied Digital, the stock is down approximately 1%.

AI-Drug Research, Computing, & Autonomous Driving Round Out NVIDIA’s 13F Portfolio

Recursion Pharmaceuticals Today

Recursion Pharmaceuticals, Inc. stock logo
RXRXRXRX 90-day performance
Recursion Pharmaceuticals
$4.20 +0.11 (+2.57%)
As of 03:29 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
52-Week Range
$3.79
$12.36
Price Target
$7.60

NVIDIA’s fourth largest 13F holding is the clinical-stage drug company, Recursion Pharmaceuticals NASDAQ: RXRX.

The company has no medicines approved by regulators yet, and thus doesn’t generate much revenue.

Overall, the company’s free cash flow over the last 12 months was around -$400 million.

The company is attempting to use AI to accelerate drug discovery and development.

Importantly, Recursion is an NVIDIA customer that uses the firm’s chips to power its supercomputer to achieve its mission.

It is prioritizing work on four cancer treatments and two rare disease treatments.

Even after jumping 24% the day NVIDIA revealed its initial investment in February 2024, shares are down 51%.

Nebius Group Today

Nebius Group N.V. stock logo
NBISNBIS 90-day performance
Nebius Group
$38.13 -0.79 (-2.02%)
As of 03:29 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
52-Week Range
$14.09
$50.87
Price Target
$50.67

NVIDIA’s final two holdings are Nebius Group NASDAQ: NBIS and WeRide NASDAQ: WRD, each making up around 2% of its portfolio.

Nebius’s business model is also very similar to CoreWeave’s, which is renting out AI computing power. 

Like CoreWeave, it is also seeing incredible revenue growth, reporting a 385% increase in sales in Q1.

Nebius will be among the first companies that will offer NVIDIA’s new Blackwell Ultra AI factory platform.

Despite rising 7% on the day the initial NVIDIA investment came out, investors have seen shares drop nearly 7% overall.

WeRide Today

WeRide Inc. stock logo
WRDWRD 90-day performance
WeRide
$10.15 -0.11 (-1.07%)
As of 03:10 PM Eastern
52-Week Range
$6.03
$44.00

Last up is WeRide. The company operates a variety of robotaxis and other autonomous driving vehicle platforms, primarily in China.

WeRide uses NVIDIA’s advanced chips to operate its technology.

Even including the 83% surge in shares after NVIDIA revealed its initial investment in February, they have fallen nearly 40% overall since then as of May 21.

NVIDIA’s 13F Holdings: Prudent Examination Still Reigns Supreme

There is one clear common thread among all these companies in which NVIDIA is investing: they are either customers or suppliers of NVIDIA. This makes sense considering that NVIDIA would deeply understand their businesses.

Overall, having investments from NVIDIA doesn't mean investors should blindly follow behind the tech giant and invest in these stocks.

This is especially true as merely associating with NVIDIA can often drive wild up moves in these names, only to see their shares crater back to earth.

Still, NVIDIA's investment is a positive, and directing a watchful eye toward these names makes sense.

Should You Invest $1,000 in NVIDIA Right Now?

Before you consider NVIDIA, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and NVIDIA wasn't on the list.

While NVIDIA currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Leo Miller
About The Author

Leo Miller

Contributing Author

Fundamental Analysis, Economics, Industry and Sector Analysis

Like this article? Share it with a colleague.

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
NVIDIA (NVDA)
4.777 of 5 stars
$133.99+1.7%0.03%52.71Moderate Buy$164.84
CoreWeave, Inc. Class A Common Stock (CRWV)N/A$109.28+1.8%N/AN/AHold$58.44
ARM (ARM)
3.1217 of 5 stars
$129.85-0.5%N/A170.70Moderate Buy$152.76
Applied Digital (APLD)
3.798 of 5 stars
$7.63+12.5%N/A-4.41Buy$10.91
Nebius Group (NBIS)
1.9383 of 5 stars
$38.53-1.0%N/A-67.74Buy$50.67
WeRide (WRD)N/A$10.09-1.7%N/AN/AN/AN/A
Recursion Pharmaceuticals (RXRX)
2.4233 of 5 stars
$4.22+3.1%N/A-2.75Hold$7.60
Compare These Stocks  Add These Stocks to My Watchlist 

Featured Articles and Offers

Related Videos

4 Biotech Stocks on the Verge of Massive Breakthroughs
New AI Deals Just Sent These 4 Infrastructure Stocks Soaring
5 Stocks to BUY NOW in May 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines